Fruitful partnerships

VelosBio marks the first start-up to emerge from Arix’s partnerships

By Chris Lieu, Staff Writer | Oct 5, 2018 | 11:20 PM GMT

Arix Bioscience plc (LSE:ARIX) leveraged its partnership with Takeda Ventures to co-lead a $58 million series A round for antibody-drug company VelosBio Inc., a sign that the VC’s strategic partnerships are finally bearing fruit.

Also participating

Read the full 351 word article

User Sign In